Osstem Implant, a global leader in dental solutions, has announced its participation in the upcoming FDI World Dental Congress (FDIWDC25), taking place September 9-12 at the National Exhibition and Convention Center in Shanghai, China.
Co-organized by the FDI World Dental Federation and the Chinese Stomatological Association, the congress is expected to attract over 30,000 dental professionals and industry stakeholders from 134 countries.
Osstem’s TS implant series, a key component of its product portfolio and a strong seller globally, will be featured prominently in Hall 5.2, Stand E61 (near Gate 20).
The booth will be divided into three areas: an implant area, a digital area focused on surgical guides, and a display of dental equipment, including dental chairs, CBCT machines, and intraoral scanners.
Together, these areas highlight Osstem’s strength as a fully integrated supplier, capable of independently developing and manufacturing its products.
Booth visitors will have the opportunity to participate in hands-on activities, experience implant placement using specialized kits, and explore Osstem’s digital solutions firsthand.
The company will highlight the clinically proven reliability and safety of TS implants, including the TS SA implant, which features a sandblasted and acid-etched surface, and the TS CA implant, which features a hydrophilic surface designed to promote blood clot formation.
TS implants have gained widespread recognition in South Korea, the United States, Japan, and China, making them a focal point at this year’s show.
In addition to Osstem products, the company will also showcase its flagship ET implant, in partnership with its US-based sister company, Hiossen.
Manufactured in Philadelphia, Hiossen implants have been recognized by the US federal government for their role in expanding exports, receiving the prestigious Presidential “E” Award in 2023.
Earlier this year, Osstem signed an exclusive distribution agreement with US dental implant company ZimVie for the Chinese market. At the Shanghai show, Osstem will have a dedicated ZimVie booth showcasing Osseotite implants.
The implants provide stable treatment results even in compromised bone. These implants have a high clinical success rate and are not shown to increase the risk of peri-implantitis.
“The Chinese dental implant market continues to grow, and dentists are more eager than ever to find solutions that meet the diverse needs of their patients,” said Heesoo Kim, Managing Director of Osstem Implants China.
At our booth, visitors can experience the value of our renowned high-quality and affordable TS implants, as well as premium products from Hiossen and ZimVie—all in one place.”
